Century Therapeutics, Inc. (IPSC) Social Stream
CENTURY THERAPEUTICS INC (IPSC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IPSC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 4 | $40 | $33 | $36.25 | $3.19 | 1036.36% |
| 2022-03-17 | 4 | $40 | $32 | $36 | $3.19 | 1028.53% |
| 2022-03-25 | 4 | $40 | $28 | $34.5 | $3.19 | 981.5% |
| 2022-04-28 | 4 | $40 | $27 | $33.25 | $3.19 | 942.32% |
| 2022-05-17 | 5 | $40 | $27 | $33.25 | $3.19 | 942.32% |
| 2022-05-23 | 6 | $34 | $22 | $26.666 | $3.19 | 735.92% |
| 2022-08-12 | 7 | $34 | $22 | $26 | $3.19 | 715.05% |
| 2022-09-17 | 8 | $28 | $22 | $25.142 | $3.19 | 688.15% |
| 2022-10-10 | 8 | $28 | $22 | $25.5 | $3.19 | 699.37% |
| 2022-10-14 | 9 | $28 | $20 | $24.625 | $3.19 | 671.94% |
| 2022-11-15 | 9 | $28 | $15 | $23.555 | $3.19 | 638.4% |
| 2022-12-27 | 10 | $28 | $15 | $23.1 | $3.19 | 624.14% |
| 2023-01-05 | 11 | $28 | $15 | $22.636 | $3.19 | 609.59% |
| 2023-01-08 | 11 | $28 | $14 | $20.454 | $3.19 | 541.19% |
| 2023-01-12 | 11 | $28 | $14 | $20 | $3.19 | 526.96% |
| 2023-02-09 | 10 | $28 | $14 | $19.8 | $3.19 | 520.69% |
| 2023-03-22 | 10 | $28 | $14 | $19.3 | $3.19 | 505.02% |
| 2023-05-12 | 10 | $28 | $12 | $19.1 | $3.19 | 498.75% |
| 2023-06-06 | 9 | $28 | $12 | $18.666 | $3.19 | 485.14% |
| 2023-08-10 | 9 | $28 | $10 | $17.555 | $3.19 | 450.31% |
| 2023-08-11 | 10 | $28 | $10 | $17.333 | $3.19 | 443.35% |
| 2023-08-28 | 10 | $28 | $5 | $14.777 | $3.19 | 363.23% |
| 2023-09-28 | 10 | $22 | $5 | $14.111 | $3.19 | 342.35% |
| 2023-11-13 | 9 | $22 | $10 | $15.125 | $3.19 | 374.14% |
The Trend in the Analyst Price Target
IPSC's average price target has moved down $4.43 over the prior 30 weeks.
IPSC reports an average of 629.34% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-12 | 11 | 28 | 14 | 19.800 | 4.80 | 312.5% |
| 2023-01-12 | 11 | 28 | 14 | 20.000 | 4.80 | 316.67% |
| 2023-05-12 | 10 | 28 | 12 | 18.666 | 3.28 | 469.09% |
| 2023-08-11 | 10 | 28 | 10 | 17.333 | 2.80 | 519.04% |
| 2023-08-28 | 10 | 28 | 5 | 14.777 | 2.51 | 488.73% |
IPSC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.22 | 8 | 0 | 1 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 52 weeks, IPSC's average broker recommendation rating worsened by 0.03.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- IPSC has a greater upside potential (average analyst target price relative to current price) than 3318.66% of all US stocks.
- IPSC has a higher number of analysts covering the stock than 2914.8% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, CENTURY THERAPEUTICS INC's variance in analysts' estimates is lower than -1352.61% of them.
- In terms of how CENTURY THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 2062.58% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CENTURY THERAPEUTICS INC are AMAM, ICVX, and OMGA.
View All Top Stocks by Price Target
Make investment decisions regarding IPSC using the data that counts. Try POWR Ratings for free.